Triple combo cystic fibrosis therapy Kaftrio scores EU label expansion
29th April 2021 Uncategorised 0Extension means the ‘majority’ of people aged 12 years and older with CF in Europe can now access therapy
More: Triple combo cystic fibrosis therapy Kaftrio scores EU label expansion
Source: News
